AddLife AB
Company Profile
Business description
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in two segments: Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals and laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.
Contact
Brunkebergstorg 5
Box 3145
Stockholm103 62
SWET: +46 842003830
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
2,322
Stocks News & Analysis
stocks
10 best US growth stocks to buy for the long term
stocks
Higher fair value for overvalued ASX tech share
stocks
Nvidia: Collaboration with Intel might bring some goodwill with the US
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,102.10 | 11.70 | 0.13% |
CAC 40 | 7,805.86 | 47.73 | -0.61% |
DAX 40 | 23,469.95 | 169.46 | -0.72% |
Dow JONES (US) | 46,224.48 | 90.79 | -0.20% |
FTSE 100 | 9,214.98 | 1.69 | -0.02% |
HKSE | 26,344.14 | 200.96 | -0.76% |
NASDAQ | 22,678.43 | 46.95 | 0.21% |
Nikkei 225 | 45,493.66 | 447.85 | 0.99% |
NZX 50 Index | 13,141.54 | 90.12 | -0.68% |
S&P 500 | 6,667.31 | 2.95 | 0.04% |
S&P/ASX 200 | 8,810.90 | 11.40 | 0.13% |
SSE Composite Index | 3,828.58 | 8.49 | 0.22% |